In 2016, Ms. Hile was a contract project management consultant for inVentiv Health Clinical and was promoted to the clinical operations lead in 2017 when the company transitioned into Syneos Health.
INDIANAPOLIS, December 19, 2023 /24-7PressRelease/ — Laura E. Hile has been included in Marquis Who’s Who. As in all Marquis Who’s Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
With more than two decades of excellence in clinical research, Ms. Hile has earned distinction as a senior clinical trial manager for Worldwide Clinical Trials. Since 2021, she has focused her efforts on overseeing the work of the clinical research associates assigned to her study while reviewing data and reporting any deviations from the protocols. She is passionate about ensuring the integrity of the work as well as the care and respect both the patients and their caregivers receive, aiming to full the gaps in the healthcare system by providing her insights and knowledge of the field.
Prior to her current role, Ms. Hile served as a medical writer for Eli Lilly and Company in 2000 and worked in several other roles in global recruitment and clinical trial registry until 2012. She subsequently worked as a senior clinical research associate for Quintiles in 2013 and became a clinical project manager for Roche Diabetes Care, Inc. through Real Staffing in 2015.
In 2016, Ms. Hile was a contract project management consultant for inVentiv Health Clinical and was promoted to the clinical operations lead in 2017 when the company transitioned into Syneos Health. She continued her career as a clinical trial manager for PRA Health Sciences in 2020. To prepare for her career, she earned a bachelor’s degree in history from Butler University in 1987.
Looking to the future, Ms. Hile intends to step down from her everyday management duties, allowing her to contribute her knowledge and expertise to policy-making or work with an organization that prioritizes patient experiences. She is also interested in engaging with the FDA’s initiative to include more minority patients and populations in clinical research, believing clinical research should not be limited to only affluent or White patients who can afford to take time off from work.
About Marquis Who’s Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who’s Who in America®, Marquis Who’s Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Marquis celebrates its 125th anniversary in 2023, and Who’s Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® publications may be visited at the official Marquis Who’s Who® website at www.marquiswhoswho.com.
# # #
